BON.F 26.9 (+0.75%)
FR0000061129Drug ManufacturersDrug Manufacturers - Specialty & Generic

Boiron (BON.F) Stock Highlights

26.9 | +0.75%
2024-12-21 05:13:24
Boiron is a drug manufacturer that focuses on homeopathic products. The companys revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boirons nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The companys products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Statistics

Range Today
26.6 26.9
Volume Today 6
Range 1 Year
26 42.2
Volume 1 Year 3K
Range 3 Year
26 56.6
Volume 3 Year 7.5K
Range 10 Year
26 110.85
Volume 10 Year 59.69K

Highlights

Market Capitalization 608.85M (small)
Floating Shares 4.1M
Current Price 26.9
Price To Earnings 23.9
Price To Revenue 1.09
Price To Book 1.51
Earnings Per Share 1.36
Dividend Yield 4.16%
Dividend Per Share 1.35
Payout Ratio 99.26%

Performance

Latest +0.75%
1 Month -9.12%
3 Months -17.1%
6 Months -19.58%
1 Year -33.25%
3 Years -21.23%
5 Years -20.18%
10 Years -62.04%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.